Immunic, Inc.IMUXNASDAQ

Revenue (LTM)

Net Income (LTM)

$-97M

+3.3% YoY

Free Cash Flow

$-86M

Revenue CAGR (5Y)

—

—Marginsstable

FCF($0.1B)

Unprofitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	0	0	0	0	0
Gross Profit	0	0	0	0	-0
Operating Income	-92	-119↓30.4%	-99↑17.0%	-98↑1.2%	-103↓5.3%
Net Income	-93	-120↓29.5%	-94↑22.3%	-101↓7.4%	-97↑3.3%
EBITDA	-92	-86↑5.6%	-99↓14.7%	-98↑1.2%	-97↑0.9%
EPS Diluted	-3.92	-3.78↑3.6%	-2.11↑44.2%	-1.00↑52.6%	-0.62↑38.0%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	87	107↑22.9%	47↓56.3%	36↓23.6%	15↓56.6%
Total Current Assets	105	126↑19.9%	53↓58.3%	39↓25.1%	23↓41.9%
Total Assets	139	128↓8.2%	54↓57.5%	41↓24.7%	24↓41.1%
Total Current Liabilities	11	13↑14.7%	25↑89.1%	22↓10.3%	31↑38.1%
Total Liabilities	12	14↑17.4%	25↑80.3%	22↓11.5%	31↑36.9%
Total Equity	127	114↓10.6%	29↓74.6%	18↓36.3%	-7↓136.2%
Total Debt	1	2↑57.6%	1↓14.7%	1↓24.7%	1↓31.9%
Net Debt	-86	-105↓22.5%	-45↑56.9%	-35↑23.5%	-15↑57.3%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	-83	-65↑21.7%	-71↓8.7%	-85↓19.7%	-86↓1.2%
Capital Expenditure	-0	-0↓67.2%	-0↓198.2%	-0↑21.0%	-0↑39.0%
Free Cash Flow	-83	-65↑21.7%	-71↓9.1%	-85↓19.5%	-86↓1.1%
Stock-Based Comp	6	8↑33.3%	7↓10.4%	9↑20.1%	9↑3.9%
Net Change in Cash	-41	20↑149.0%	-60↓402.1%	-11↑81.7%	-20↓83.4%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance